The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions

Alzheimer’s disease (AD) is the leading cause of dementia affecting almost 50 million people worldwide. The ε4 allele of Apolipoprotein E (APOE) is the strongest known genetic risk factor for late-onset AD cases, with homozygous APOE4 carriers being approximately 15-times more likely to develop the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hunsberger, Holly C., Pinky, Priyanka D., Smith, Warren, Suppiramaniam, Vishnu, Reed, Miranda N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2019
Materias:
Aging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104324/
https://www.ncbi.nlm.nih.gov/pubmed/32269835
http://dx.doi.org/10.1042/NS20180203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104324/
https://www.ncbi.nlm.nih.gov/pubmed/32269835
http://dx.doi.org/10.1042/NS20180203

Ejemplares similares